Thu, March 2, 2023
Wed, March 1, 2023
Tue, February 28, 2023

Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $55 on, Mar 1st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-55-on-mar-1st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $58 to $55 on, Mar 1st, 2023.

Bradley has made no other calls on ZNTL in the last 4 months.



There are 5 other peers that have a rating on ZNTL. Out of the 5 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Bradley


  • Robert Driscoll of "Wedbush" Maintained at Buy with Decreased Target to $32 on, Monday, November 14th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $55 on, Friday, November 11th, 2022
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Decreased Target to $28 on, Friday, November 11th, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $27 on, Thursday, November 10th, 2022
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $50 on, Thursday, November 10th, 2022

Publication Contributing Sources